| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BEW
|
0.71 | 247.8M | 0.78 | 0.69 | 0.81 | 25.3% | 8.6% | 85 | 84 | 1.90 | +123.8% | 68 | 0.75 |
|
Q01
|
0.98 | 563.8M | 3.73 | 1.16 | 1.62 | 9.8% | 13.0% | 83 | 61 | 1.83 | +64.3% | 84 | 0.05 |
|
D03
|
0.07 | 136.1M | 0.70 | — | 0.89 | 106.2% | 5.2% | 80 | 86 | 0.20 | +142.9% | 67 | -1.20 |
|
DM0
|
0.49 | 267.2M | 3.36 | 0.76 | 0.78 | 9.8% | 11.3% | 80 | 65 | 1.19 | +108.2% | 83 | 0.23 |
|
P34
|
0.77 | 470.6M | 3.47 | 1.31 | 1.95 | 12.2% | 13.1% | 79 | 62 | 1.29 | +50.6% | 85 | 0.06 |
|
Y03
|
0.56 | 352.6M | 4.13 | 0.63 | — | -4.6% | 13.1% | 69 | 30 | 1.06 | +50.0% | 75 | 0.03 |
|
BQD
|
0.37 | 112.5M | 0.91 | 1.45 | 1.22 | — | — | 68 | 51 | 0.75 | +75.7% | 61 | 4.04 |
|
F03
|
2.27 | 1.5B | 5.15 | 3.19 | 3.40 | 24.2% | 11.4% | 61 | 59 | 2.14 | -4.4% | 86 | 0.24 |
|
VC2
|
1.03 | 3.9B | 32.78 | 0.41 | 2.56 | 2.8% | 5.9% | 59 | 57 | 1.59 | +40.8% | 61 | 1.19 |
|
533
|
0.40 | 80.4M | 25.12 | 0.84 | 15.63 | -2.3% | 11.0% | 32 | 22 | 0.24 | -22.5% | 50 | 0.55 |
|
579
|
0.00 | 77.6M | — | 1.50 | 10.49 | -1.0% | 8.8% | 20 | 28 | 0.00 | -100.0% | 36 | 2.19 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.